Loading organizations...
Loading organizations...
Therapies for autoimmune and allergic diseases with immune system reset.
Revolo Biotherapeutics has raised $52.3M across 1 funding round.
Revolo Biotherapeutics has raised $52.3M in total across 1 funding round.
Revolo Biotherapeutics has raised $52.3M in total across 1 funding round.
Revolo Biotherapeutics's investors include Metellus, Isaac Cheng, 24Haymarket.
Revolo Biotherapeutics has raised $52.3M across 1 funding round. Most recently, it raised $52.3M Series B in September 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 21, 2020 | $52.3M Series B | Metellus, Isaac Cheng | 24Haymarket |